Caris Life Sciences to Present at the 2025 ASCO Genitourinary Cancers Symposium
In collaboration with leading cancer centers, research results to be presented from three studies across two tumor types Caris Life Sciences®(Caris), a leading next-generation AI TechBio company and precision medicine pioneer, announced today that the company and collaborators within the Caris Precision Oncology Alliance™(Caris POA)will collectively present three studies at the 2025 American Society of […]